Unitaid
room Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland
arrow_back See all Activities

Market entry of an improved solid protease inhibitor-based first-line ARV combination therapy for infants and young children with HIV/AIDS

IATI Identifier:

Published on IATI
  • date_range May 31, 2013 - Dec 31, 2018
  • autorenew Implementation (Status)

The Project will be implemented with a view to increasing access to optimal ART for children under three years and will involve the development of three products through the DNDi’s partnership with Cipla

more_horiz

Participating Organisations

Drugs for Neglected Diseases initiative (DNDi) Foundation Implementing

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

2,971,489 USD
  • 2,971,489 USD (Valued at Dec 31, 2018)
    date_range Jan 01, 2018 - Dec 31, 2018
access_time Updated on Nov 09, 2020 15:51:09